Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prothena Corp Public (PRTA) Return on Sales (2016 - 2025)

Historic Return on Sales for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to 15.12%.

  • Prothena Corp Public's Return on Sales rose 457100.0% to 15.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.79%, marking a year-over-year decrease of 228100.0%. This contributed to the annual value of 0.9% for FY2024, which is 7000.0% up from last year.
  • Latest data reveals that Prothena Corp Public reported Return on Sales of 15.12% as of Q3 2025, which was up 457100.0% from 28.45% recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Return on Sales peaked at 0.78% during Q3 2021, and registered a low of 1444.78% during Q1 2024.
  • In the last 5 years, Prothena Corp Public's Return on Sales had a median value of 27.31% in 2024 and averaged 115.55%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -14231700bps in 2024, then surged by 14235000bps in 2025.
  • Quarter analysis of 5 years shows Prothena Corp Public's Return on Sales stood at 28.28% in 2021, then soared by 100bps to 0.13% in 2022, then plummeted by -169282bps to 213.53% in 2023, then skyrocketed by 87bps to 27.31% in 2024, then surged by 45bps to 15.12% in 2025.
  • Its Return on Sales was 15.12% in Q3 2025, compared to 28.45% in Q2 2025 and 21.28% in Q1 2025.